M. Bergsaker

发表

Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule.

D. Caugant, I. Aaberge, E. Høiby, 2010, Vaccine.

Public health implications of an outbreak of rabies in arctic foxes and reindeer in the Svalbard archipelago, Norway, September 2011.

K. Handeland, L. Vold, E. Macdonald, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.

I. Kristiansen, T. Wisløff, T. Abrahamsen, 2006, Vaccine.

Decline in Early Childhood Respiratory Tract Infections in the Norwegian Mother and Child Cohort Study After Introduction of Pneumococcal Conjugate Vaccination

S. London, P. Nafstad, H. Stigum, 2012, The Pediatric infectious disease journal.

Immunogenicity of a 2-Dose Priming and Booster Vaccination With the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine

B. Høgh, S. Silfverdal, D. Borys, 2009, The Pediatric infectious disease journal.

Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle Vaccine

E. Rosenqvist, I. Aaberge, H. Nøkleby, 2006, Clinical and Vaccine Immunology.

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial

V. Usonis, S. Esposito, B. Innis, 2014, The Lancet.

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.

D. Caugant, I. Aaberge, E. Høiby, 2008, Vaccine.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

A. Steens, I. Aaberge, D. Vestrheim, 2013, Vaccine.

Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC).

S. Mamelund, J. Yarwood, J. Tuells, 2010, Vaccine.

Vaccination coverage for seasonal influenza among residents and health care workers in Norwegian nursing homes during the 2012/13 season, a cross-sectional study

J. Bjørnholt, S. Hauge, M. Bergsaker, 2014, BMC Public Health.

Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years

H. Nøkleby, M. Bergsaker, I. L. Haugen, 2015, BMC Pediatrics.

Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination

E. Sanders, M. Valenciano, A. van der Ende, 2018, Thorax.

A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older

A. Steens, I. Aaberge, J. Storsaeter, 2014, Epidemiology and Infection.

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.

D. Caugant, I. Aaberge, E. Høiby, 2008, Vaccine.